Physician profile
Joel E Moses
NPI 1477661205
$229.74
in general payments reported to CMS, 2019-2025
8 companies · $47.01 in 2025
The $47.01 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $11.95 · 2023: $18.84 · 2024: $46.59 · 2025: $47.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $68.87 | 2019-2024 | Rezzayo, Orbactiv, Kimyrsa |
| Insmed, INC. | $47.01 | 2025 | Arikayce |
| Abbvie INC. | $25.82 | 2024 | |
| Janssen Biotech, INC. | $22.24 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.84 | 2023 | Lifevest |
| Allergan, INC. | $18.24 | 2019 | |
| Astellas Pharma US INC | $16.69 | 2019 | |
| Merck Sharp & Dohme LLC | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.